Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

134.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
134.9K
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

1.7K
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
1.7K
Neurotransmitters01:31

Neurotransmitters

4.1K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
4.1K
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Bipolar Disorder01:30

Bipolar Disorder

1.5K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.5K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

887
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
887

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proposal for Circadian Rhythms and Their Behavioral Outputs as Biomarkers in <i>DSM-6</i>: Response to Cuthbert et al.

The American journal of psychiatry·2026
Same author

Modulation of early non-rapid eye movement slow wave activity by ketamine in treatment-resistant depression.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Mu-Opioid Signaling Engagement as a Candidate Maintenance Mechanism for Prolonging Ketamine's Antisuicidal Effects.

The American journal of psychiatry·2026
Same author

Major depressive disorder is associated with reduced intrinsic connectivity between the bed nucleus of the stria terminalis and ventral striatum.

Journal of psychiatry & neuroscience : JPN·2026
Same author

Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis.

JAMA psychiatry·2026
Same author

Mechanistic Underpinnings of Emotional Face Processing in Suicide Risk: Exploring the Moderating Effects of Cortisol on Neural Parameters Using Magnetoencephalography.

Psychiatric research and clinical practice·2026

Related Experiment Video

Updated: Apr 20, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

752

Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Robin Ortiz1, Henning Ulrich2, Carlos A Zarate1

  • 1Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Division of Intramural Research Programs, National Institutes of Health, Bethesda, MD, USA.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|December 3, 2014
PubMed
Summary

The purinergic system, involving uric acid and adenosine, is crucial for mood regulation. Targeting this system shows promise for treating mood disorders like bipolar disorder (BD) with antidepressant and cognitive benefits.

Keywords:
Bipolar disorderDepressionManiaPurinesTreatmentUric acid

More Related Videos

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

19.0K
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.8K

Related Experiment Videos

Last Updated: Apr 20, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

752
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

19.0K
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.8K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Psychiatry

Background:

  • Purinergic system, involving uric acid and adenosine, influences mood, sleep, cognition, and impulsivity.
  • A century-old hypothesis links purinergic dysfunction to mood disorders.
  • Recent studies show elevated gout risk in bipolar disorder (BD) patients and benefits of purinergic modulators in mania.

Purpose of the Study:

  • To review the critical role of the purinergic system in the pathophysiology of mood disorders.
  • To highlight the purinergic system as a potential therapeutic target for mood disorders.

Main Methods:

  • Review of existing literature, including genetic studies, population-based research, and meta-analyses.
  • Discussion of neuroimaging techniques like brain spectroscopy and Positron Emission Tomography (PET) for studying the purinergic system.

Main Results:

  • Uric acid levels correlate with energy and activity in the BD spectrum.
  • Genetic studies implicate P1 and P2 receptor subtypes in mood disorders.
  • Purinergic modulators have demonstrated benefits in bipolar mania.

Conclusions:

  • The purinergic system is a key player in mood disorder pathophysiology.
  • Targeting the purinergic system offers potential for developing novel therapies with antidepressant, mood-stabilizing, and cognitive-enhancing effects.